Osteopetrosis in mice lacking NF-κB1 and NF-κB2

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1285-1289

  Iotsova, Violetta ^a   Caamaño, Jorge ^a   Loy, James ^a   Yang, Yi ^a   Lewin, Anne ^a   Bravo, Rodrigo ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ALBERS SCHOENBERG DISEASE; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; CELL DIFFERENTIATION; INFLAMMATION; OSTEOCLAST; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030715563     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197-1285     Document Type: Article

References (24)

1. Grilli, M., Chiu, J. & Lenardo, M. NF-κB and Rel: Participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143, 1-62 (1993).
2. Kabrun, N. & Enrietto, P. The Rel family of proteins in oncogenesis and differentiation. Semin. Cancer Biol. 5, 103-112 (1994).
3. Kopp, E. & Ghosh, S. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58, 1-27 (1995).
4. Sha, W., Liou, H.-C., Tuomanen, E. & Baltimore, D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330 (1995).
5. Minkin, C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34, 285-293 (1982).
6. Takahashi, N. et al. Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev. Biol. 163, 212-221 (1994).
7. Manolagas, S.C. Role of cytokines in bone resorption. Bone 17, 63S-67S (1995).
8. Grigoriadis, A.E., Schellander, K., Wang, Z.-Q. & Wagner, E.F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122, 685-701 (1993).
9. Pralet, B., Male, P., Neff, L. & Baron, R. Identification of a functional mononuclear precursor of the osteoclast in chicken medullary bone marrow cultures. J. Bone Miner. Res. 7, 405-414 (1992).
10. Johnson, R.S., Spiegelman, B.M. & Papaioannou, V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71, 577-586 (1992).
11. Wang, Z.-Q., et al. Bone and haematopoietic defects in mice lacking c-fos. Nature 360, 741-745 (1992).
12. Stein, B., et al. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12, 3879-3891 (1993).
13. Grigoriadis, A.E., Wang, Z.-Q. & Wagner, E. Fos and bone cell development: Lessons from a nuclear oncogene. Trends Genet. 11, 436-442 (1995).
14. Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702 (1991).
15. Suda, T., Udagawa, N., Nakamura, I., Miyaura, C. & Takahashi, N. Modulation of osteoclast differentiation by local factors. Bone 17, 87S-91S (1995).
16. Vortkamp, A., et al. Regulation of rate of cartilage differentiation by Indian Hedgehog and PTH-related protein. Science 273, 613-622 (1996).
17. Weir, E., et al. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc. Natl. Acad. Sci. USA 93, 10240-10245 (1996).
18. Jimi E., et al. Interleukin-1 alfa activates an NF-kappaB-like factor in osteoclast-like cells. J. Biol. Chem. 271, 4605-4608 (1996).
19. Whyte, M.P. Carbonic anhydrase II deficiency. Clin. Orthop. Relat. Res. 294, 52-63 (1993).
20. Manolagas, S.C., Bellido, T. & Jilka, R.L. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp130. Int. J. Immunopharmacol. 17, 109-116 (1995).
21. Stein, B. & Yang, M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol. Cell. Biol. 15, 4971-4979 (1995).
22. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, W. Isolation and Fractionation of Mononuclear Cell Populations. (Wiley, New York, 1992).
23. Grigoriadis, A.E., et al. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448 (1994).
24. Tondravi, M.M., et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81-84 (1997).